Please provide your email address to receive an email when new articles are posted on . Patients with primary thyroid cancer who received radioactive iodine therapy had elevated risk for melanoma/skin ...

SAN DIEGO — Radioactive iodine (RAI) shows benefit in improving overall survival among papillary-thyroid carcinoma patients across all tumor size categories, including the very smallest, according to ...

Feasibility of 6 months of maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck (HNC). This is an ASCO Meeting Abstract from ...

Graphical Abstract. Relative survival with and without radioiodine therapy (RAI) in intermediate risk papillary thyroid cancer (PTC) and low risk, minimally invasive follicular thyroid cancer (FTC). A ...

Although survival rates are high, thyroid cancer patients often face unnecessary treatments due to the reliance on inaccurate ...

Radioactive iodine treatment after thyroid cancer surgery usually means side effects like nausea and time in hospital isolated from loved ones. But new clinical trial results from researchers at UCL ...

Who Provides Psychosocial Follow-Up Care for Post-Treatment Cancer Survivors? A Survey of Medical Oncologists and Primary Care Physicians We recruited 74 patients with early-stage PTC after ...

Please provide your email address to receive an email when new articles are posted on . Among a group of patients with differentiated thyroid cancer, 10-year disease-specific survival was 97.2%.

Radioactive iodine (RAI) treatment was associated with an increased risk of developing Graves' orbitopathy (GO) in patients with thyroid cancer. Patients who developed GO received significantly higher ...